In vivo vaccination effect in multiple myeloma patients treated with the monoclonal antibody isatuximab

Leukemia. 2020 Jan;34(1):317-321. doi: 10.1038/s41375-019-0536-3. Epub 2019 Aug 13.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Neoplasm / immunology*
  • Antigens, Neoplasm / immunology*
  • Antineoplastic Agents, Immunological / therapeutic use*
  • Humans
  • Membrane Proteins / immunology
  • Multiple Myeloma / drug therapy*
  • Multiple Myeloma / immunology*
  • Pilot Projects

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Neoplasm
  • Antigens, Neoplasm
  • Antineoplastic Agents, Immunological
  • CTAG1B protein, human
  • Membrane Proteins
  • isatuximab